5-HT1B receptor antagonists administered alone or with antidepressants have been shown to be effective in preclinical models of depression; the activation of 5-HT1B heteroceptors induces antidepressant-like behavior. The gene discussed is HTR1B; the disease is depressive symptom measurement.